Inactive Instrument
Fresh Tracks Therapeutics, Inc. Stock
Stocks
FRTX
US10802T2042
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -0.53% |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Marchio
CEO | Chief Executive Officer | 74 | 2023-10-01 |
Nancy Seretta
CTO | Chief Tech/Sci/R&D Officer | - | 2015-12-31 |
Aaron Fox-Collis
DFI | Director of Finance/CFO | - | 2022-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Albert Marchio
CHM | Chairman | 74 | 2023-10-01 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24-06-06 | Exploration Capital LLC
| Buy | Company | 405,500 | 6.7885% | |
| 24-05-28 | Exploration Capital LLC
| Buy | Company | 10,434 | 0.1747% | |
| 24-05-20 | Exploration Capital LLC
| Buy | Company | 22,889 | 0.3832% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.53% | +2.75% | - | - | 5.59M | ||
| -0.68% | +5.57% | +46.84% | +107.96% | 54.81B | ||
| -2.63% | -6.51% | +46.06% | +45.81% | 42.96B | ||
| +1.17% | -5.67% | -20.27% | -20.62% | 21.62B | ||
| +5.17% | -6.59% | +34.53% | +394.46% | 20.41B | ||
| -1.45% | -13.52% | +21.46% | -31.25% | 16.03B | ||
| -0.03% | -1.74% | +11.41% | -40.09% | 15.28B | ||
| +2.42% | +5.39% | +23.15% | +173.85% | 13.01B | ||
| +1.41% | -11.02% | +14.48% | - | 11.37B | ||
| +1.28% | -9.04% | -30.60% | +676.63% | 10.95B | ||
| Average | +0.61% | -5.62% | +16.34% | +163.34% | 22.94B | |
| Weighted average by Cap. | +0.09% | -3.38% | +26.46% | +123.29% |
Employees
4
















